Literature DB >> 19062296

Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis.

Toshiyuki Harada1, Yoshiaki Nakagawa, Randy M Wadkins, Philip M Potter, Craig E Wheelock.   

Abstract

Carboxylesterases are enzymes that hydrolyze a broad suite of endogenous and exogenous ester-containing compounds to the corresponding alcohol and carboxylic acid. These enzymes metabolize a number of therapeutics including the anti-tumor agent CPT-11, the anti-viral drug oseltamivir, and the anti-thrombogenic agent clopidogrel as well as many agrochemicals. In addition, carboxylesterases are involved in lipid homeostasis, including cholesterol metabolism and transport with a proposed role in the development of atherosclerosis. Several different scaffolds capable of inhibiting carboxylesterases have been reported, including organophosphates, carbamates, trifluoromethyl ketone-containing structures (TFKs), and aromatic ethane-1,2-diones. Of these varied groups, only the 1,2-diones evidence carboxylesterase isoform-selectivity, which is an important characteristic for therapeutic application and probing biological mechanisms. This study constructed a series of classical and 3D-QSAR models to examine the physiochemical parameters involved in the observed selectivity of three mammalian carboxylesterases: human intestinal carboxylesterase (hiCE), human carboxylesterase 1 (hCE1), and rabbit carboxylesterase (rCE). CoMFA-based models for the benzil-analogs described 88%, 95% and 76% of observed activity for hiCE, hCE1 and rCE, respectively. For TFK-containing compounds, two distinct models were constructed using either the ketone or gem-diol form of the inhibitor. For all three enzymes, the CoMFA ketone models comprised more biological activity than the corresponding gem-diol models; however the differences were small with described activity for all models ranging from 85-98%. A comprehensive model incorporating both benzil and TFK structures described 92%, 85% and 87% of observed activity for hiCE, hCE1 and rCE, respectively. Both classical and 3D-QSAR analysis showed that the observed isoform-selectivity with the benzil-analogs could be described by the volume parameter. This finding was successfully applied to examine substrate selectivity, demonstrating that the relative volumes of the alcohol and acid moieties of ester-containing substrates were predictive for whether hydrolysis was preferred by hiCE or hCE1. Based upon the integrated benzil and TFK model, the next generation inhibitors should combine the A-ring and the 1,2-dione of the benzil inhibitor with the long alkyl chain of the TFK-inhibitor in order to optimize selectivity and potency. These new inhibitors could be useful for elucidating the role of carboxylesterase activity in fatty acid homeostasis and the development of atherosclerosis as well as effecting the controlled activation of carboxylesterase-based prodrugs in situ.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19062296      PMCID: PMC2752023          DOI: 10.1016/j.bmc.2008.11.008

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  40 in total

1.  Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol.

Authors:  Man Tang; Madhu Mukundan; Jian Yang; Nathan Charpentier; Edward L LeCluyse; Chris Black; Dongfang Yang; Deshi Shi; Bingfang Yan
Journal:  J Pharmacol Exp Ther       Date:  2006-08-30       Impact factor: 4.030

2.  Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.

Authors:  Janice L Hyatt; Teri Moak; M Jason Hatfield; Lyudmila Tsurkan; Carol C Edwards; Monika Wierdl; Mary K Danks; Randy M Wadkins; Philip M Potter
Journal:  J Med Chem       Date:  2007-03-23       Impact factor: 7.446

3.  Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel.

Authors:  Deshi Shi; Jian Yang; Dongfang Yang; Edward L LeCluyse; Chris Black; Li You; Fatemeh Akhlaghi; Bingfang Yan
Journal:  J Pharmacol Exp Ther       Date:  2006-09-11       Impact factor: 4.030

4.  Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1.

Authors:  Sompop Bencharit; Carol C Edwards; Christopher L Morton; Escher L Howard-Williams; Peter Kuhn; Philip M Potter; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2006-08-15       Impact factor: 5.469

5.  Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabun.

Authors:  Christopher D Fleming; Carol C Edwards; Stephen D Kirby; Donald M Maxwell; Philip M Potter; Douglas M Cerasoli; Matthew R Redinbo
Journal:  Biochemistry       Date:  2007-04-04       Impact factor: 3.162

6.  Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compounds.

Authors:  Randy M Wadkins; Janice L Hyatt; Carol C Edwards; Lyudmila Tsurkan; Matthew R Redinbo; Craig E Wheelock; Paul D Jones; Bruce D Hammock; Philip M Potter
Journal:  Mol Pharmacol       Date:  2006-12-13       Impact factor: 4.436

7.  Evaluation of the 'side door' in carboxylesterase-mediated catalysis and inhibition.

Authors:  Timothy M Streit; Abdolsamad Borazjani; Shellaine E Lentz; Monika Wierdl; Philip M Potter; Steven R Gwaltney; Matthew K Ross
Journal:  Biol Chem       Date:  2008-02       Impact factor: 3.915

8.  Influence of sulfur oxidation state and steric bulk upon trifluoromethyl ketone (TFK) binding kinetics to carboxylesterases and fatty acid amide hydrolase (FAAH).

Authors:  Craig E Wheelock; Kosuke Nishi; Andy Ying; Paul D Jones; Michael E Colvin; Marilyn M Olmstead; Bruce D Hammock
Journal:  Bioorg Med Chem       Date:  2007-11-26       Impact factor: 3.641

9.  Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils.

Authors:  Latorya D Hicks; Janice L Hyatt; Teri Moak; Carol C Edwards; Lyudmila Tsurkan; Monika Wierdl; Antonio M Ferreira; Randy M Wadkins; Philip M Potter
Journal:  Bioorg Med Chem       Date:  2007-03-12       Impact factor: 3.641

10.  Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.

Authors:  Janice L Hyatt; Randy M Wadkins; Lyudmila Tsurkan; Latorya D Hicks; M Jason Hatfield; Carol C Edwards; Charles R Ross; Stephanie A Cantalupo; Guy Crundwell; Mary K Danks; R Kip Guy; Philip M Potter
Journal:  J Med Chem       Date:  2007-10-17       Impact factor: 7.446

View more
  7 in total

1.  Reversible inhibitory effects of saturated and unsaturated alkyl esters on the carboxylesterases activity in rat intestine.

Authors:  Ping Li; Chun-Liu Zhu; Xin-Xin Zhang; Li Gan; Hong-Zhen Yu; Yong Gan
Journal:  Lipids       Date:  2010-06-08       Impact factor: 1.880

2.  Absorption enhancement of adefovir dipivoxil by incorporating MCT and ethyl oleate complex oil phase in emulsion.

Authors:  Ping Li; Hong-zhen Yu; Xin-xin Zhang; Li Gan; Chun-liu Zhu; Yong Gan
Journal:  Acta Pharmacol Sin       Date:  2010-06-21       Impact factor: 6.150

3.  In Silico Design and Evaluation of Carboxylesterase Inhibitors.

Authors:  Shana V Stoddard; Xiaozhen Yu; Philip M Potter; Randy M Wadkins
Journal:  J Pest Sci (2004)       Date:  2010       Impact factor: 5.918

4.  Dual Role of Glyoxal in Metal-Free Dicarbonylation Reaction: Synthesis of Symmetrical and Unsymmetrical Dicarbonyl Imidazoheterocycles.

Authors:  Nitesh Kumar Nandwana; Om P S Patel; Manu R Srivathsa; Anil Kumar
Journal:  ACS Omega       Date:  2019-06-11

5.  Detailed quantum mechanical, molecular docking, QSAR prediction, photovoltaic light harvesting efficiency analysis of benzil and its halogenated analogues.

Authors:  Y Shyma Mary; Y Sheena Mary; K S Resmi; Veena S Kumar; Renjith Thomas; B Sureshkumar
Journal:  Heliyon       Date:  2019-11-14

6.  I2-Catalyzed Carbonylation of α-Methylene Ketones to Synthesize 1,2-Diaryl Diketones and Antiviral Quinoxalines in One Pot.

Authors:  Lingkai Kong; Jieru Meng; Wenyue Tian; Jiazheng Liu; Xueping Hu; Zhi-Hong Jiang; Wei Zhang; Yanzhong Li; Li-Ping Bai
Journal:  ACS Omega       Date:  2021-12-21

7.  Toxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptors.

Authors:  Christophe Morisseau; Oleg Merzlikin; Amy Lin; Guochun He; Wei Feng; Isela Padilla; Michael S Denison; Isaac N Pessah; Bruce D Hammock
Journal:  Environ Health Perspect       Date:  2009-07-31       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.